Lana Medical Co. reported a profit of SAR 2 million for the first half of 2025, compared to SAR 1.1 million in the same period of 2024.
Item | H1 2024 | H1 2025 | Change |
---|---|---|---|
Revenues | 33.66 | 47.72 | 41.8 % |
Net Income | 1.07 | 1.98 | 85.6 % |
Average Shares | 5.40 | 5.40 | - |
Earnings Per Share before unusual items (Riyal) | 0.20 | 0.37 | 85.6 % |
EPS (Riyal) | 0.20 | 0.37 | 85.6 % |
Item | H2 2024 | H1 2025 | Change |
---|---|---|---|
Revenues | 50.42 | 47.72 | (5.4 %) |
Net Income | 9.24 | 1.98 | (78.6 %) |
Average Shares | 5.40 | 5.40 | - |
Earnings Per Share before unusual items (Riyal) | 0.86 | 0.37 | (57.5 %) |
EPS (Riyal) | 1.71 | 0.37 | (78.6 %) |
The profit growth during the six-month period was attributed to a 41.76% rise in revenues, supported by an expanded market share and government projects that boosted sales, in addition to improved service quality.
Compared to H2 2024, Lana’s profit dropped by 78.6% from SAR 9.24 million.
Shareholders’ equity, with no minority interest, stood at SAR 63.56 million at the end of H1 2025, compared to SAR 49.83 million in the same period last year.
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: